Abstrakt

Przypisy

• 1. Al-Awqati Q., Oliver J.A.: Stem cells in the kidney. Kidney Int., 2002; 61: 387-395
  Google Scholar
• 2. Caliskan B., Guven A., Ozler M., Cayci T., Ozcan A., Bedir O., Surer I., Korkmaz A.: Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis. Scand. J. Clin. Lab. Invest., 2011; 71: 473-480
  Google Scholar
• 3. Casaz P., Garrity-Ryan L.K., McKenney D., Jackson C., Levy S.B., Tanaka S.K., Alekshun M.N.: MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology, 2006; 152: 3643-3650
  Google Scholar
• 4. Chen L.X., Koyner J.L.: Biomarkers in acute kidney injury. Crit. Care Clin., 2015; 31: 633-648
  Google Scholar
• 5. Dennen P., Altmann C., Kaufman J., Klein C.L., Andres-Hernando A., Ahuja N.H., Edelstein C.L., Cadnapaphornchai M.A., Keniston A., Faubel S.: Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. Crit. Care, 2010; 14: R181
  Google Scholar
• 6. Duława J.: Zakażenia układu moczowego. In: Choroby dróg moczowych, Nefrologia. Wielka interna. Myśliwiec M. (ed.). Medical Tribune Polska, Warszawa 2009, 330-342
  Google Scholar
• 7. Emamghorashi F., Owji S.M., Motamedifar M.: Evaluation of effectiveness of vitamins C and E on prevention of renal scar due to pyelonephritis in rat. Adv. Urol., 2011; 2011: 489496
  Google Scholar
• 8. Fahimi D., Mohajeri S., Hajizadeh N., Madani A., Esfahani S.T., Ataei N., Mohsseni P., Honarmand M.: Comparison between fractional excretions of urea and sodium in children with acute kidney injury. Pediatr. Nephrol., 2009; 24: 2409-2412
  Google Scholar
• 9. Görür S., Celik S., Hakverdi S., Aslantaş O., Erdoğan S., Aydin M., Ocak S., Namik Kiper A.: Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats. Urology, 2008; 72: 743-748
  Google Scholar
• 10. Gotfried J., Wiesen J., Raina R., Nally J.V. Jr.: Finding the cause of acute kidney injury: which index of fractional excretion is better? Cleve. Clin. J. Med., 2012; 79: 121-126
  Google Scholar
• 11. Heyman S.N., Brezis M., Reubinoff C.A., Greenfeld Z., Lechene C., Epstein F.H., Rosen S.: Acute renal failure with selective medullary injury in the rat. J. Clin. Invest., 1988; 82: 401-412
  Google Scholar
• 12. Hopkins W.J., Gendron-Fitzpatrick A., Balish E., Uehling D.T.: Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect. Immun., 1998; 66: 2798-2802
  Google Scholar
• 13. Hummers-Pradier E., Kochen M.M.: Urinary tract infections in adult general practice patients. Br. J. Gen. Pract., 2002; 52: 752-761
  Google Scholar
• 14. Husain S., Alroumoh M., Mohan P., El-Kass G., Seshan S.V., Galler M.: Acute kidney injury from pyelonephritis in an elderly man: case report. Int. Urol. Nephrol., 2011; 43: 925-928
  Google Scholar
• 15. Jörres A.: Acute kidney injury in sepsis: transient or intrinsic? Crit. Care, 2013; 17: 1014
  Google Scholar
• 16. Labib M., Khalid R., Khan A., Khan S.: Volume management in the critically ill patient with acute kidney injury. Crit. Care Res. Pract., 2013; 2013: 792830
  Google Scholar
• 17. Langenberg C., Wan L., Bagshaw S.M., Egi M., May C.N., Bellomo R.: Urinary biochemistry in experimental septic acute renal failure. Nephrol. Dial. Transplant., 2006; 21: 3389-3397
  Google Scholar
• 18. Lee D.G., Cho J.J., Park H.K., Kim D.K., Kim J.I., Chang S.G., Lee S.J.: Preventive effects of hyaluronic acid on Escherichia coliinduced urinary tract infection in rat. Urology, 2010; 75: 949-954
  Google Scholar
• 19. Lisowska-Myjak B.: Laboratory markers of acute kidney injury detected in serum and urine. Forum Nefrol., 2010; 3: 71-81
  Google Scholar
• 20. Lüthje P., Brauner A.: Virulence factors of uropathogenic E. coli and their interaction with the host. Adv. Microb. Physiol., 2014; 65: 337-372
  Google Scholar
• 21. Malekinejad H., Nikibakhsh A., Gholizadeh-Soltani S., Farshid A.: Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis. Indian J. Nephrol., 2012; 22: 26-32
  Google Scholar
• 22. Matuszkiewicz-Rowińska J.: Acute kidney injury and RIFLE classification: advantages and disadvantages. Nefrol. Dial. Pol., 2008; 12: 248-250
  Google Scholar
• 23. Molitoris B.A., Sutton T.A.: Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int., 2004; 66: 496-499
  Google Scholar
• 24. Nahar A., Akom M., Hanes D., Briglia A., Drachenberg C.B., Weinman E.J.: Pyelonephritis and acute renal failure. Am. J. Med. Sci., 2004; 328: 121-123
  Google Scholar
• 25. Nanda N., Juthani-Mehta M.: Novel biomarkers for the diagnosis of urinary tract infection – a systematic review. Biomark. Insights, 2009; 4: 111-121
  Google Scholar
• 26. Needham E.: Management of acute renal failure. Am. Fam. Physician, 2005; 72: 1739-1746
  Google Scholar
• 27. Palevsky P.M.: Acute kidney failure. Neph. SAP, 2003; 2: 41-76
  Google Scholar
• 28. Palevsky M.P., Murray P.T.: Acute kidney injury and critical care nephrology. Neph. SAP, 2006; 5: 72
  Google Scholar
• 29. Pickering J.W., Endre Z.H.: The definition and detection of acute kidney injury. J. Renal Inj. Prev., 2013; 3: 21-25
  Google Scholar
• 30. Rugo H.S., O’Hanley P., Bishop A.G., Pearce M.K., Abrams J.S., Howard M., O’Garra A.: Local cytokine production in a murine model of Escherichia coli pyelonephritis. J. Clin. Invest., 1992; 89: 1032-1039
  Google Scholar
• 31. Russell W.M., Burch R.L.: The Principles of Humane Experimental Technique. 1959; London
  Google Scholar
• 32. Sener G., Tuğtepe H., Velioğlu-Oğünç A., Cetinel S., Gedik N., Yeğen B.C.: Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats. J. Pineal Res., 2006; 41: 220-227
  Google Scholar
• 33. Skowron B., Juszczak K., Baranowska A., Machowska A., Strus M., Więcek G., Heczko P., Thor P.J.: Laboratory diagnostics of renal function in an experimental model of ascending pyelonephritis with high-virulent Escherichia coli. Folia Med. Cracov, 2012; 52: 25-37
  Google Scholar
• 34. Sutton T.A., Fisher C.J., Molitoris B.A.: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int., 2002; 62: 1539-1549
  Google Scholar
• 35. Tancheva S., Valcheva-Kuzmanova S.V., Radev R.Z., Marinov M.D., Boychev B., Stoeva T., Boyadjieva S.K., Nenov K.S.: A model of experimental acute hematogenous pyelonephritis in the rat. Folia Med., 2011; 53: 63-68
  Google Scholar
• 36. The ad-hoc working group of ERBP: Fliser D., Laville M., Covic A., Fouque D., Vanholder R., Juillard L., Van Biesen W.: A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol. Dial. Transplant., 2012; 27: 4263-4272
  Google Scholar
• 37. Turner M.E., Weinstein J., Kher K.: Acute renal failure secondary to pyelonephritis. Pediatrics, 1996; 97: 742-743
  Google Scholar
• 38. Westwood M.E., Whiting P.F., Cooper J., Watt I.S., Kleijnen J.: Further investigation of confirmed urinary tract infection (UTI) in children under five years: a systematic review. BMC Pediatr., 2005; 5: 2
  Google Scholar
• 39. Wilding E.I., Kim D.Y., Bryant A.P., Gwynn M.N., Lunsford R.D., McDevitt D., Myers J.E. Jr., Rosenberg M., Sylvester D., Stauffacher C.V., Rodwell V.W.: Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus. J. Bacteriol., 2000; 182: 5147-5152
  Google Scholar
• 40. Yagmurlu A., Boleken M.E., Ertoy D., Ozsan M., Gokcora I.H., Dindar H.: Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. Urology, 2003; 61: 1037-1041
  Google Scholar
• 41. Yoshida M., Honma S.: Regeneration of injured renal tubules. J. Pharmacol. Sci., 2014; 124: 117-122
  Google Scholar

Pełna treść artykułu